In the pursuit of longevity, an unconventional contender has emerged: rapamycin, a generic drug that's captivating the attention of those eager to extend their lifespan. What began as a niche interest among a select group...
Tag : Controversy
In an unexpected turn of events, Dataminr, a leading big data enterprise valued at $4.1 billion, announced a significant reduction in its workforce. The New York-based company, renowned for its innovative use of AI and...